Evaluating the primary care clinical pharmacist visit transition to telehealth during the COVID-19 pandemic by comparing medication related problems from telehealth visits and in-person visits.

ABSTRACT:

Background

The coronavirus disease 2019 (COVID-19) pandemic forced healthcare systems to rethink healthcare delivery, and forced primary care pharmacists in our healthcare system to switch all visits that were previously face to face (FTF) to telehealth.

Methods

We conducted a retrospective observational cohort study to examine the association between medication related problems (MRPs) resolved in telehealth vs FTF primary care clinical pharmacist visits. The telehealth visits took place in the context of the COVID-19 pandemic, which forced health care systems to rethink care delivery. Data was collected for patient visits for 2 weeks in January before the pandemic and 2 weeks in June during the pandemic.

Results

There was significantly more average MRPs resolved per

SUBMITTER: McNamara A 

PROVIDER: S-EPMC8426712 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature